Jeil Pharma Holdings Inc (KRX:002620)

South Korea · Delayed Price · Currency is KRW

8,210.00

+70.00 (0.86%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Investment Sector	14.65B	13.69B	11.61B	11.92B	17.03B
Investment Sector Growth	7.04%	17.86%	-2.56%	-30.02%	11.34%
Pharmaceutical Sector	794.70B	818.40B	812.94B	778.72B	773.34B
Pharmaceutical Sector Growth	-2.90%	0.67%	4.39%	0.70%	4.22%
Consolidated Adjustments	-29.53B	-28.04B	-31.59B	-28.07B	-28.37B
Total	779.82B	804.04B	792.96B	762.57B	762.00B
Total Growth	-3.01%	1.40%	3.99%	0.07%	4.13%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	756.49B	777.17B	786.91B	761.64B	748.51B
South Korea Growth	-2.66%	-1.24%	3.32%	1.75%	4.90%
Consolidated Adjustments	-29.53B	-28.04B	-31.59B	-30.07B	-28.37B
Overseas	52.86B	54.92B	37.64B	31.00B	41.86B
Overseas Growth	-3.75%	45.90%	21.43%	-25.94%	-4.39%

Source: S&P Global Market Intelligence.